Sweden · Delayed Price · Currency is SEK Meds Apotek AB Statistics
Total Valuation
Meds Apotek AB has a market cap or net worth of SEK 412.30 million. The enterprise value is 345.49 million.
| Market Cap | 412.30M |
| Enterprise Value | 345.49M |
Important Dates
The next confirmed earnings date is Tuesday, July 21, 2026.
| Earnings Date | Jul 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Meds Apotek AB has 18.57 million shares outstanding. The number of shares has increased by 6.58% in one year.
| Current Share Class | 18.57M |
| Shares Outstanding | 18.57M |
| Shares Change (YoY) | +6.58% |
| Shares Change (QoQ) | +1.25% |
| Owned by Insiders (%) | 13.10% |
| Owned by Institutions (%) | 25.23% |
| Float | 15.00M |
Valuation Ratios
The trailing PE ratio is 53.90 and the forward PE ratio is 12.96.
| PE Ratio | 53.90 |
| Forward PE | 12.96 |
| PS Ratio | 0.40 |
| PB Ratio | 3.09 |
| P/TBV Ratio | 3.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 45.61 |
| EV / Sales | 0.33 |
| EV / EBITDA | 42.45 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.61 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.58 |
| Debt / FCF | -0.58 |
| Interest Coverage | -3.61 |
Financial Efficiency
Return on equity (ROE) is 7.88% and return on invested capital (ROIC) is -1.53%.
| Return on Equity (ROE) | 7.88% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -1.53% |
| Return on Capital Employed (ROCE) | -2.01% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 21.11M |
| Profits Per Employee | 154,571 |
| Employee Count | 49 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -10.55M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 24.59 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 42.49 |
| Average Volume (20 Days) | 84,803 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Meds Apotek AB had revenue of SEK 1.03 billion and earned 7.57 million in profits. Earnings per share was 0.41.
| Revenue | 1.03B |
| Gross Profit | 233.47M |
| Operating Income | -2.71M |
| Pretax Income | -2.98M |
| Net Income | 7.57M |
| EBITDA | -658,000 |
| EBIT | -2.71M |
| Earnings Per Share (EPS) | 0.41 |
Balance Sheet
The company has 71.54 million in cash and 4.73 million in debt, with a net cash position of 66.82 million or 3.60 per share.
| Cash & Cash Equivalents | 71.54M |
| Total Debt | 4.73M |
| Net Cash | 66.82M |
| Net Cash Per Share | 3.60 |
| Equity (Book Value) | 133.65M |
| Book Value Per Share | 7.20 |
| Working Capital | 92.15M |
Cash Flow
In the last 12 months, operating cash flow was -2.69 million and capital expenditures -5.41 million, giving a free cash flow of -8.10 million.
| Operating Cash Flow | -2.69M |
| Capital Expenditures | -5.41M |
| Depreciation & Amortization | 2.06M |
| Net Borrowing | -9.01M |
| Free Cash Flow | -8.10M |
| FCF Per Share | -0.44 |
Margins
Gross margin is 22.57%, with operating and profit margins of -0.26% and 0.73%.
| Gross Margin | 22.57% |
| Operating Margin | -0.26% |
| Pretax Margin | -0.29% |
| Profit Margin | 0.73% |
| EBITDA Margin | -0.06% |
| EBIT Margin | -0.26% |
| FCF Margin | n/a |
Dividends & Yields
Meds Apotek AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.58% |
| Shareholder Yield | -6.58% |
| Earnings Yield | 1.84% |
| FCF Yield | -1.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Meds Apotek AB is 47.50, which is 113.96% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 47.50 |
| Price Target Difference | 113.96% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 14.53% |
| EPS Growth Forecast (3Y) | 56.67% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Meds Apotek AB has an Altman Z-Score of 4.98 and a Piotroski F-Score of 1.
| Altman Z-Score | 4.98 |
| Piotroski F-Score | 1 |